EMA details lifecycle approach to AI/ML drug development in new reflection paper

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsEuropeMedical DevicesPharmaceuticalsPreclinical studyProduct Lifecycle